Paper41214734
Wuling San ameliorates cerebral ischemia-reperfusion injury via suppression of the TRPM2/NLRP3 pathway.
Li H and 5 others. Eur J Med Res, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Wuling San ameliorates cerebral ischemia-reperfusion injury via suppression of the TRPM2/NLRP3 pathway. Papers, record 41214734. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41214734
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Wuling San ameliorates cerebral ischemia-reperfusion injury via suppression of the TRPM2/NLRP3 pathway.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| TRPM Cation Channels | Major topic |
| Reperfusion Injury | Major topic |
| NLR Family, Pyrin Domain-Containing 3 Protein | Major topic |
| Drugs, Chinese Herbal | Major topic |
| Brain Ischemia | Major topic |
| Animals | |
| Mice | |
| Male | |
| Signal Transduction | |
| Mice, Inbred C57BL | |
| Oxidative Stress | |
| Disease Models, Animal |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82274620 | the National Natural Science Foundation of China | PubMed | ||
| XKF2023009 | Fujian Provincial Key Laboratory of Cognitive Rehabilitation, Fujian Provincial Key Laboratory of Rehabilitation Technology, Open Project of Traditional Chinese Medicine Rehabilitation Discipline | PubMed |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35021129 | Down-regulation of TRPM2 attenuates hepatic ischemia/reperfusion injury through activation of autophagy and inhibition of NLRP3 inflammasome pathway. | Int Immunopharmacol | 2022 | https://conductscience.org/library/papers/35021129 | PubMed |
| 2 | 39582857 | The interplay between ferroptosis and inflammation: therapeutic implications for cerebral ischemia-reperfusion. | Front Immunol | 2024 | https://conductscience.org/library/papers/39582857 | PubMed |
| 3 | 37962044 | Combining Network Pharmacology, Molecular Docking and Preliminary Experiments to Explore the Mechanism of Action of FZKA Formula on Non-small Cell Lung Cancer. | Protein Pept Lett | 2023 | https://conductscience.org/library/papers/37962044 | PubMed |
| 4 | 40341937 | Molecular mechanisms of programmed cell death and potential targeted pharmacotherapy in ischemic stroke (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/40341937 | PubMed |
| 5 | 32251636 | Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion. | Life Sci | 2020 | https://conductscience.org/library/papers/32251636 | PubMed |
| 6 | 32674019 | Oxidative stress activates the TRPM2-Ca2+-NLRP3 axis to promote PM2.5-induced lung injury of mice. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/32674019 | PubMed |
| 7 | 38438409 | NRF2 activation ameliorates blood-brain barrier injury after cerebral ischemic stroke by regulating ferroptosis and inflammation. | Sci Rep | 2024 | https://conductscience.org/library/papers/38438409 | PubMed |
| 8 | 35387495 | Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities. | Stroke | 2022 | https://conductscience.org/library/papers/35387495 | PubMed |
| 9 | 37788785 | Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice. | J Ethnopharmacol | 2024 | https://conductscience.org/library/papers/37788785 | PubMed |
| 10 | 32296107 | Resveratrol attenuates hypoxia-induced neuronal cell death, inflammation and mitochondrial oxidative stress by modulation of TRPM2 channel. | Sci Rep | 2020 | https://conductscience.org/library/papers/32296107 | PubMed |
| 11 | 39804950 | Traditional Chinese Medicine Borneol-Based Polymeric Micelles Intracerebral Drug Delivery System for Precisely Pathogenesis-Adaptive Treatment of Ischemic Stroke. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39804950 | PubMed |
| 12 | 37695472 | TGN-020 Alleviate Inflammation and Apoptosis After Cerebral Ischemia-Reperfusion Injury in Mice Through Glymphatic and ERK1/2 Signaling Pathway. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/37695472 | PubMed |
| 13 | 39496572 | CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate-Induced Excitotoxicity Through a Reduction of NOX-2 Activity and Oxidative Stress. | CNS Neurosci Ther | 2024 | https://conductscience.org/library/papers/39496572 | PubMed |
| 14 | 38934281 | Extracts from Artemisia annua Alleviates Myocardial Remodeling through TGF-β1/Smad2/3 Pathway and NLRP3 Inflammasome | Curr Mol Pharmacol | 2024 | https://conductscience.org/library/papers/38934281 | PubMed |
| 15 | 25269821 | Inhibition of Src phosphorylation reduces damage to the blood-brain barrier following transient focal cerebral ischemia in rats. | Int J Mol Med | 2014 | https://conductscience.org/library/papers/25269821 | PubMed |
| 16 | 26579420 | Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage. | Acta Pharm Sin B | 2015 | https://conductscience.org/library/papers/26579420 | PubMed |
| 17 | 31002919 | NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. | Life Sci | 2019 | https://conductscience.org/library/papers/31002919 | PubMed |
| 18 | 37595268 | Activation of endothelial TRPM2 exacerbates blood-brain barrier degradation in ischemic stroke. | Cardiovasc Res | 2024 | https://conductscience.org/library/papers/37595268 | PubMed |
| 19 | 28132925 | Combined NADPH and the NOX inhibitor apocynin provides greater anti-inflammatory and neuroprotective effects in a mouse model of stroke. | Free Radic Biol Med | 2017 | https://conductscience.org/library/papers/28132925 | PubMed |
| 20 | 39007141 | Bidirectional regulation mechanism of TRPM2 channel: role in oxidative stress, inflammation and ischemia-reperfusion injury. | Front Immunol | 2024 | https://conductscience.org/library/papers/39007141 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42857491 | Ischemic Stroke and Traumatic Brain Injury: Epidemiology, Molecular Pathways, and Emerging Therapies. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42857491 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41214734
GET https://conductscience.org/api/papers/v1/41214734/references?page=2